Piotr Rutkowski

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (17)

vanna chiarion sileni

Chief of Melanoma Oncology Unit

ITALY

View details

Paweł Sobczuk

Medical University of Warsaw

POLAND

View details

Paweł Teterycz

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Dorota Sulejczak

Associate Professor, PhD; Editor-in-Chief of Folia Neuropathologica; Head of Department of Experimental Pharmacology

Mossakowski Medical Research Centre

POLAND

View details

Anna Szumera-Ciećkiewicz

Head of Biobank; Senior Consultant Pathologist

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

John Kirkwood

Distinguished Service Professor of Medicine

University of Pittsburgh

UNITED STATES

View details

Claudio Bucolo

Associate Professor

Università degli Studi di Napoli Federico II

ITALY

View details

Kamil Drucis

Medical University of Gdansk

POLAND

View details

Anna Czarnecka

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Dirk Schadendorf

University Hospital Essen

GERMANY

View details

Hans Gelderblom

Prof.dr.

Leiden University Medical Center

NETHERLANDS

View details

Magdalena Rosińska

current position: Head of Department

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Bozena Cybulska-Stopa

Chief

Wrocław University of Scince and Technology

POLAND

View details

Michele Reibaldi

Professore Ordinario

University of Turin

ITALY

View details

Céleste Lebbé

Université Paris Cité

FRANCE

View details

BARTLOMIEJ SZOSTAKOWSKI

Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie

POLAND

View details

Michal Fiedorowicz

Assistant Professor

Mossakowski Medical Research Centre

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Piotr Rutkowski

Research Interests

Explore related searches

Contact this professor

Articles (20)

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma

Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study

MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma

Recent advances in tyrosine kinase inhibitors VEGFR 1-3 for the treatment of advanced metastatic melanoma

CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib

Detrimental effect of COVID-19 pandemic on patients with extremity bone sarcoma. Reference center experience

Establishing biomarkers for soft tissue sarcomas

Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma

Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial

Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment

Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials

In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma

Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials

Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions

New roads in retroperitoneal sarcomas

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

Perioperative Therapy in Melanoma: Several Questions Still Remain

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study

Collaborators (17)

vanna chiarion sileni

Paweł Sobczuk

Paweł Teterycz

Dorota Sulejczak

Anna Szumera-Ciećkiewicz

John Kirkwood

Claudio Bucolo

Kamil Drucis

Anna Czarnecka

Dirk Schadendorf

Hans Gelderblom

Magdalena Rosińska

Bozena Cybulska-Stopa

Michele Reibaldi

Céleste Lebbé

BARTLOMIEJ SZOSTAKOWSKI

Michal Fiedorowicz

Make your next move.